InvestorWire NewsRoom

InvestorNewsBreaks

Thursday May 15, 2025 - 9:00 am

InvestorNewsBreaks – SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) to Report Q1 2025 Results and Host Investor Webinar Today 

Disseminated on behalf of SolarBank Corporation  SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) will release its financial results for the quarter ended March 31, 2025, after market close today, May 15, and will host a webinar at 4:30 p.m. ET to provide a business update and discuss the quarterly performance.  To view the full press release, visit https://ibn.fm/PSk5q  About SolarBank Corporation  SolarBank Corporation is…

Continue Reading

Thursday May 15, 2025 - 9:00 am

InvestorNewsBreaks – NextPlat Corp (NASDAQ: NXPL) Reports Q1 Revenue of $14.5M, Expands Airtime Business Despite Healthcare Headwinds

NextPlat (NASDAQ: NXPL, NXPLW) reported Q1 2025 revenue of $14.5 million, down from $17.5 million in the prior year, driven by changes in 340B pharmacy agreements and prescription volume. Gross margin declined to 23.8%, while operating expenses fell 26% to $4.9 million due to reduced legal and non-recurring costs. Net loss narrowed to $1.3 million, or ($0.05) per share. The company ended the quarter with…

Continue Reading

Wednesday May 14, 2025 - 3:20 pm

InvestorNewsBreaks – NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Set to Report Q1 Earnings in Wake of HOPE’s Strategic Kadima Agreement 

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) is scheduled to report its first quarter 2025 financial results after the market closes on Thursday, May 15. A conference call and webcast will follow at 4:30 p.m. ET, accessible via the company’s investor relations site or by dialing +1-800-717-1738 (U.S.) or +1-646-307-1865 (international).  The earnings update comes shortly after news that NRx’s wholly owned subsidiary, HOPE Therapeutics, signed a…

Continue Reading

Wednesday May 14, 2025 - 3:13 pm

InvestorNewsBreaks – Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) Positioned to Accelerate Storm Copper Project in Nunavut

Aston Bay (TSX.V: BAY) (OTCQB: ATBHF), through its joint venture with American West Metals, has secured a strategic partnership with Ocean Partners Holdings to significantly advance the Storm Copper Project in Nunavut, Canada. The deal includes up to 80% project development financing and a binding offtake agreement granting Ocean Partners exclusive rights to copper and silver products from near-surface mineralization. Backed by a US$3.5 million…

Continue Reading

Wednesday May 14, 2025 - 2:49 pm

InvestorNewsBreaks – Whoopi Goldberg to Take the Stage at CMB 2025 

Cannabis Means Business (“CMB”) today announced that Whoopi Goldberg will participate in a fireside chat and launch her new hemp-derived beverage, Whoop-Tea, at CMB 2025, taking place on June 4–5 at the Javits Center in New York City. The Emmy, Grammy, Oscar, and Tony Award-winning entertainer and entrepreneur will join CNBC’s Tim Seymour on Wednesday, June 4, for an exclusive conversation in the Special Events…

Continue Reading

Wednesday May 14, 2025 - 12:15 pm

InvestorNewsBreaks – From Farm to Future: Sustainability in Focus at Sustain SoCal’s May Event

Sustain Southern California (“Sustain SoCal”) has announced its upcoming event, Agriculture, Food Systems and Waste Stream Innovations, slated to take place in Irvine, California, on Thursday, May 15, 2025. The synergistic agenda will drive comprehensive discussions along the entire spectrum of the supply chain, from agtech, farm-to-table, packaging innovations, and waste management policy. “We are pleased to offer a new initiative… which shall provide a…

Continue Reading

Wednesday May 14, 2025 - 11:49 am

InvestorNewsBreaks – SurgePays, Inc. (Nasdaq: SURG) Secures $7M Convertible Note to Fuel LinkUp Mobile Launch and Wholesale Expansion 

SurgePays (Nasdaq: SURG) has entered into a $7 million senior secured convertible note agreement with a current institutional shareholder, providing $6 million in cash and involving a repurchase of 333,333 shares. The two-year note is convertible into common stock at $4.00 per share, a premium to current market price, and includes a prepayment option at a 2% premium. Proceeds will support the national launch of…

Continue Reading

Wednesday May 14, 2025 - 10:00 am

InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Advances PTSD Treatment with FDA-Requested Safety Study for SPC-15

Silo Pharma (NASDAQ: SILO) has partnered with Frontage Laboratories to conduct a 7-day safety and toxicology study of its lead asset, SPC-15, following a request from the FDA. The intranasal treatment targets PTSD and stress-related disorders, and the study is expected to strengthen Silo’s upcoming IND application. Silo remains on track for an FDA submission this year and is concurrently running a GLP-compliant toxicology study.…

Continue Reading

Wednesday May 14, 2025 - 9:50 am

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Grows Q1 Revenue 29% and Narrows Losses Ahead of Investor Showcase

Knightscope (NASDAQ: KSCP) reported Q1 2025 revenue of $2.9 million, up 29% year-over-year, while net loss narrowed to $6.9 million, a 19% improvement. The company improved gross margin loss to (23%) from (64%) and cut G&A expenses by 24%. Knightscope ended the quarter with $12.7 million in cash and a $2.5 million backlog. Strategic initiatives included securing a 33,000-square-foot headquarters in Sunnyvale, California, and raising…

Continue Reading

Wednesday May 14, 2025 - 9:45 am

InvestorNewsBreaks – ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Highlights Near-Term Production Strategy on MiningNewsWire Podcast 

ESGold (CSE: ESAU) (OTCQB: ESAUF) President Brad Kitchen appeared on the latest episode of The MiningNewsWire Podcast to discuss the company’s fully permitted Montauban project and near-term path to gold and silver production. Kitchen emphasized ESGold’s unique model of funding exploration through early-stage tailings production, citing an estimated $100 million in recoverable material from the historic mine. He also highlighted the project’s community impact, operational…

Continue Reading

Wednesday May 14, 2025 - 9:40 am

InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Appoints Joseph Hand as General Counsel and EVP of Operations

Tonix Pharmaceuticals (NASDAQ: TNXP) has appointed Joseph Hand, Esq., as General Counsel and Executive Vice President of Operations. Hand brings decades of leadership experience across legal, HR, and corporate services, including a pivotal role in Celgene’s $74 billion acquisition by Bristol Myers Squibb and the $13.4 billion divestiture of Otezla® to Amgen. His addition comes as Tonix prepares for a potential launch of TNX-102 SL…

Continue Reading

Wednesday May 14, 2025 - 9:35 am

InvestorNewsBreaks – NanoViricides (NYSE American: NNVC) Advances NV-387 Antiviral as Measles and MPox Resurge Globally 

NanoViricides, Inc. (NYSE American: NNVC) provided a strategic update on its antiviral pipeline, highlighting NV-387 as a potential breakthrough treatment for Measles and MPox amid rising global case counts and vaccine failures. The company has begun preparations for animal efficacy studies for Measles and will make NV-387 available under FDA’s Individual Patient Expanded Access. In the DRC, its Phase II Clinical Trial Application for MPox…

Continue Reading

Wednesday May 14, 2025 - 9:30 am

InvestorNewsBreaks – FAVO Capital Inc. (FAVO) to Present Growth Strategy at D. Boral Capital Inaugural Global Conference 

FAVO Capital (OTC: FAVO), a provider of revenue-based funding solutions for SMBs, announced its participation in the D. Boral Capital Inaugural Global Conference on May 14, 2025, at The Plaza Hotel in New York City. President Shaun Quin will represent the company in meetings with institutional investors, highlighting FAVO’s growth strategy and IPO readiness. CEO Vincent Napolitano emphasized the event as a key platform to expand…

Continue Reading

Wednesday May 14, 2025 - 9:30 am

InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Hits FDA Milestone and Expands Strategic Partnerships in Q1 Update

HeartBeam (NASDAQ: BEAT) reported Q1 2025 results highlighted by successful completion of the VALID-ECG pivotal study, supporting its 510(k) submission for 12-lead ECG synthesis software and confirming productive ongoing FDA discussions. The company launched an Early Access Program, signed a strategic partnership with AccurKardia to integrate its FDA-cleared AccurECG(TM) software, added two new U.S. patents to bring its IP total to 20, appointed CEO Robert…

Continue Reading

Wednesday May 14, 2025 - 9:20 am

InvestorNewsBreaks – SOBRsafe Inc. (NASDAQ: SOBR) Appoints Kris Pederson to Board, Adds Scientific Advisor to Advance Tech and Governance

SOBRsafe (NASDAQ: SOBR) has appointed Kris Pederson, a veteran corporate director with leadership roles at EY, IBM (NYSE: IBM), and PwC, to its Board of Directors effective May 1, 2025, where she will also chair the Nominating and Corporate Governance Committee. The Company also named Dr. Benjamin Sanchez as a Scientific Advisor in February to support federal funding and clinical research partnerships. The additions bring…

Continue Reading

Wednesday May 14, 2025 - 9:20 am

InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) to Present at Alliance Global Partners Healthcare Showcase on May 21 

Cybin (NYSE American: CYBN) (NEO: CYBN) announced that CEO Doug Drysdale will participate in a fireside chat at the virtual Alliance Global Partners Healthcare Company Showcase on May 21, 2025. The session will be webcast live at 1:40 p.m. ET and later available via the company’s investor relations site.  To view the full press release, visit https://ibn.fm/6a3sj  About Cybin Inc.  Cybin is a clinical-stage biopharmaceutical…

Continue Reading

Wednesday May 14, 2025 - 9:10 am

InvestorNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Advances Phase 3 Alzheimer’s Trial and Expands Conference Presence in Q1 

Annovis Bio (NYSE: ANVS) initiated its pivotal Phase 3 clinical trial in early Alzheimer’s disease during Q1 2025, with enrollment now underway for up to 760 participants to assess buntanetap’s symptomatic and disease-modifying effects over 18 months. The company also secured a new U.S. patent for buntanetap and participated in several key scientific and investor conferences, including Oppenheimer’s 35th Annual Healthcare Life Sciences Conference and…

Continue Reading

Wednesday May 14, 2025 - 9:10 am

InvestorNewsBreaks – Ucore Rare Metals Inc. (TSXV: UCU) (OTCQX: UURAF) Expands North American REE Refining Plans as RapidSX(TM) Nears Commissioning

Ucore Rare Metals (TSXV: UCU) (OTCQX: UURAF) is nearing the commissioning of its RapidSX(TM) Commercial Demonstration Plant in Kingston, Ontario, a key milestone in its plan to commercialize its advanced rare earth element (REE) separation technology. The company is also preparing to construct its first Strategic Metals Complex (SMC) in Louisiana, expected to process 2,000 tons of total rare earth oxides by the end of…

Continue Reading

Wednesday May 14, 2025 - 9:05 am

InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Prices $5 Million Public Offering with Institutional Investor 

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company focused on brain and central nervous system cancers, has priced a “reasonable best efforts” public offering with a single healthcare-focused institutional investor, raising approximately $5 million in gross proceeds. The offering includes 3,952,570 shares of common stock at $1.265 per share and accompanying Series F warrants to purchase an equal number of shares at $1.14 per share, exercisable…

Continue Reading

Wednesday May 14, 2025 - 9:00 am

InvestorNewsBreaks – SKYX Platforms Corp. (NASDAQ: SKYX) Secures $4 Million Strategic Investment as Part of $15 Million Funding Round

SKYX Platforms (NASDAQ: SKYX), a smart home platform technology company with over 97 issued and pending patents, announced it has raised approximately $4 million from strategic investors through preferred stock priced at $2.00 per share. The investment is part of a broader $15 million financing round led by The Shaner Group, with additional participation from SKYX insiders including President Steve Schmidt and Co-CEOs Lenny Sokolow…

Continue Reading

Tuesday May 13, 2025 - 1:30 pm

InvestorNewsBreaks – MoneyShow’s Virtual Expo to Deliver Strategic Insights on Maximizing Potential in Volatile Times

MoneyShow, a leading producer of live and online financial conferences for investors, traders, and financial advisors, today announced the upcoming “Navigating Volatility, Finding Opportunity: A Virtual Expo,” set to take place May 21-22, 2025. “Investors face several key issues in this market environment. They include far-reaching U.S. tariffs, geopolitical tensions, inflation concerns, evolving trade dynamics, the potential for interest rate cuts, and the surge in…

Continue Reading

Tuesday May 13, 2025 - 10:16 am

InvestorNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Reaches Settlement Agreement with GEM Over Mishawaka Assets 

Mullen Automotive (NASDAQ: MULN), an electric vehicle manufacturer, announced it has executed a settlement agreement with GEM Yield Bahamas Limited and GEM Global Yield LLC SCS, resolving a four-year legal dispute. Under the agreement, GEM has a 55-day due diligence period—subject to extension—to evaluate the transfer of Mullen’s Mishawaka assets in full satisfaction of the judgment. All collection activities will be suspended during this period.…

Continue Reading

Tuesday May 13, 2025 - 9:50 am

InvestorNewsBreaks – FAVO Capital Inc. (FAVO) Converts Super Voting Shares to Support Nasdaq Uplisting Plans

FAVO Capital (OTC: FAVO), a private credit firm focused on merchant cash advances and revenue-based financing for underserved SMBs, announced the voluntary conversion of all outstanding Super Voting Series C Preferred Shares into common stock. The move simplifies the company’s capital structure, eliminates super voting rights, and aligns with public market governance standards as FAVO continues its preparations for a planned uplisting to the Nasdaq Capital…

Continue Reading

Tuesday May 13, 2025 - 9:45 am

InvestorNewsBreaks – Sekur Private Data Ltd. (CSE: SKUR) (OTCQX: SWISF) (FSE: GDT0) Expands Into Africa with Focus on Cybersecurity for Government and Enterprise Clients 

Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FSE: GDT0), a Swiss-hosted cybersecurity and private communications platform, has initiated discussions with multiple referral partners to launch its privacy-focused solutions across several African countries. The move targets enterprise and government clients, especially in high-risk sectors such as education, telecom, and public administration, in response to the continent’s growing exposure to cyber threats. Sekur’s communications suite, which includes…

Continue Reading

Tuesday May 13, 2025 - 9:40 am

InvestorNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Secures Australian Approval to Launch Phase II Concussion Trial

Oragenics (NYSE American: OGEN) a biotechnology company developing intranasal therapies for brain-related disorders, announced it has received approval from Australia’s Human Research Ethics Committee ("HREC") to begin a Phase II clinical trial of ONP-002, its proprietary neuroprotective therapy for mild traumatic brain injury (mTBI), or concussion. The clearance enables the company to initiate patient enrollment as early as Q2 2025 at Level 1 trauma emergency…

Continue Reading

Tuesday May 13, 2025 - 9:30 am

InvestorNewsBreaks – Intelligent Bio Solutions Inc. (Nasdaq: INBS) Grows Revenue, Cuts Losses in Fiscal Q3 as Cartridge Sales Drive Margins

Intelligent Bio Solutions (Nasdaq: INBS), a medical technology company delivering rapid, non-invasive testing solutions, reported a 20% sequential revenue increase to $728,867 in fiscal Q3 2025, driven by growth in cartridge sales, which now account for 58% of total revenue and strengthen its recurring revenue model. Gross profit surged 91% year-over-year to $341,368, while net loss narrowed by $434,141 to $2.54 million. INBS added 35…

Continue Reading

Tuesday May 13, 2025 - 9:30 am

InvestorNewsBreaks – ONAR Holding Corporation (OTCQB: ONAR) Engages IBN to Lead Corporate Communications Strategy 

ONAR (OTCQB: ONAR), a global marketing technology firm specializing in AI-driven solutions for revenue acceleration, has selected IBN to lead its corporate communications initiatives. ONAR, which operates across performance, healthcare, and experiential marketing, aims to redefine middle-market marketing through innovation and strategic acquisitions. The company is rapidly growing its global footprint and integrating specialized agencies under one brand to deliver superior client outcomes. Through this…

Continue Reading

Tuesday May 13, 2025 - 9:20 am

InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Secures Orphan Drug Designation Transfer for TPI 287 in Brain Cancer Indications

CNS Pharmaceuticals (NASDAQ: CNSP) announced the successful transfer of Orphan Drug Designation from Cortice Biosciences for its lead asset TPI 287, covering gliomas, pediatric neuroblastoma, and progressive supranuclear palsy. TPI 287, a microtubule-stabilizing abeotaxane, has shown potential to cross the blood-brain barrier and demonstrated encouraging results in a Phase 1 glioblastoma trial, including 3 complete and 9 partial responses among 23 evaluable patients. The company…

Continue Reading

Tuesday May 13, 2025 - 9:10 am

InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Prepares for Potential Fibromyalgia Drug Approval, Reports Q1 Results 

Tonix Pharmaceuticals (NASDAQ: TNXP), a fully-integrated biopharmaceutical company, announced financial results for the first quarter of 2025 and reaffirmed its focus on the anticipated FDA decision for TNX-102 SL, a non-opioid analgesic for fibromyalgia, with a PDUFA goal date of Aug. 15. If approved, it would mark the first new drug class for fibromyalgia in more than 15 years. Tonix also highlighted progress across its…

Continue Reading

Tuesday May 13, 2025 - 9:10 am

InvestorNewsBreaks – SKYX Platforms Corp. (NASDAQ: SKYX) Schedules May 14 Call to Present Q1 2025 Results and Corporate Update

SKYX Platforms (NASDAQ: SKYX), doing business as "SKYX Technologies," announced it will host a corporate update call to review its first quarter 2025 financial results on Wednesday, May 14, at 4:30 p.m. ET. The call will feature Founder and Executive Chairman Rani Kohen, President Steve Schmidt (former CEO of Nielsen Data Corporation and President of Office Depot International), Co-CEO Lenny Sokolow, and CFO Marc Boisseau.…

Continue Reading

Tuesday May 13, 2025 - 9:00 am

InvestorNewsBreaks – G Mining Ventures Corp. (TSX: GMIN) (OTCQX: GMINF) to Restate 2024 Financials for Non-Cash Foreign Exchange Adjustments 

G Mining Ventures Corp. (TSX: GMIN) (OTCQX: GMINF) announced plans to restate its 2024 consolidated financial statements and Management Discussion and Analysis due to two non-cash accounting adjustments totaling approximately $32 million related to IAS 21 foreign exchange treatment. The restatement, which has no impact on the company’s cash position, operations, or financial covenants, reclassifies $11 million in unrealized foreign exchange losses and $21 million…

Continue Reading

Tuesday May 13, 2025 - 9:00 am

InvestorNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Subsidiary HOPE Therapeutics to Acquire Kadima Neuropsychiatry Institute

NRx Pharmaceuticals (NASDAQ: NRXP) announced that its wholly owned subsidiary, HOPE Therapeutics(TM), has signed a definitive agreement to acquire the Kadima Neuropsychiatry Institute. Kadima, a leading California clinic for interventional psychiatry, offers treatments such as ketamine, Spravato, transcranial magnetic stimulation (TMS), and medication management for CNS disorders including suicidal depression and PTSD. The clinic is profitable and expected to serve as the clinical model for…

Continue Reading

Monday May 12, 2025 - 1:43 pm

InvestorNewsBreaks – Aegis Capital Corp. Serves as Sole Book-Running Manager for Super League Enterprise (NASDAQ: SLE) $869,999 Public Offering 

Aegis Capital is pleased to announce its role as the sole book-running manager in the recently completed underwritten public offering for Super League Enterprise, Inc. (NASDAQ: SLE). The offering comprised 5,117,647 shares of common stock at a public offering price of $0.17 per share, resulting in gross proceeds of approximately $869,999 before underwriting fees and expenses. The company also granted Aegis a 45-day overallotment option…

Continue Reading

Monday May 12, 2025 - 1:28 pm

InvestorNewsBreaks – CMB to Spotlight Future of Cannabis at NYC Expo 

Cannabis Means Business (“CMB”), the industry’s premier business-to-business conference and expo, today shared new details on its schedule of panels and presentations, as well as programming, exhibitions and networking opportunities. The expo will feature a lineup of engaging speakers, including CNBC Fast Money trader Tim Seymour, Philip Wolf, a pioneer of the cannabis hospitality sector. and Dr. Chanda Macias, CEO of Women Grow.  “New York's…

Continue Reading

Monday May 12, 2025 - 1:00 pm

InvestorNewsBreaks – IBN Tapped as Media Partner for DealFlow Discovery Day on Nuclear Energy

IBN (InvestorBrandNetwork), a multifaceted communications organization committed to connecting companies with the investment community through its dynamic portfolio of 60+ brands, today announced its engagement as the official media partner for DealFlow Events’ inaugural DealFlow Discovery Day on Nuclear Energy. The event is slated to take place on May 22, 2025, at the conveniently located Jay Suites in New York City. "DealFlow produces industry-flagship events…

Continue Reading

Monday May 12, 2025 - 9:33 am

InvestorNewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Signs LOI to Acquire Hilton Garden Inn Near Disney’s Cotino Project 

Nightfood Holdings (OTCQB: NGTF) announced the signing of a Letter of Intent to acquire the 120-room Hilton Garden Inn in Rancho Mirage, California for $36.93 million, marking one of the company’s largest deals to date. The hotel, adjacent to Disney’s Cotino(TM) residential resort community, will serve as a flagship site for Nightfood’s AI-powered Robotics-as-a-Service (“RaaS”) platform, which aims to reduce labor costs and enhance operational…

Continue Reading

Monday May 12, 2025 - 9:30 am

InvestorNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) to Stream Juve Stabia Finale Live in U.S., Canada and UK 

Brera Holdings (NASDAQ: BREA) announced that its Italian Serie B club S.S. Juve Stabia, known as “The Second Team of Naples,” will have its regular season finale streamed live and free on Tuesday, May 13, at 2:30 p.m. ET via Destination Calcio(TM) TV for viewers in the U.S., Canada and UK. The match, featuring Juve Stabia at home against Sampdoria, will include full English commentary…

Continue Reading

Monday May 12, 2025 - 9:10 am

InvestorNewsBreaks – NUBURU, Inc. (NYSE American: BURU) Receives Noncompliance Notice from NYSE American Over Equity Threshold

NUBURU (NYSE American: BURU) has received a Notice of Noncompliance from NYSE Regulation for failing to meet the $2 million stockholders’ equity requirement under Section 1003(a)(i) of the NYSE American Company Guide, following continued operating losses and a going concern warning in its latest 10-K. The notice does not immediately impact BURU's trading status, though its ticker now carries a ".BC" designation. The company has…

Continue Reading

Monday May 12, 2025 - 9:10 am

InvestorNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Report Q1 2025 Results on May 15 

NRx Pharmaceuticals (NASDAQ: NRXP) announced it will release its first quarter 2025 financial results after market close on Thursday, May 15, 2025. The company will host a conference call at 4:30 p.m. ET the same day to discuss the results and provide a corporate update.  To view the full press release, visit https://ibn.fm/lACTS  About NRx Pharmaceuticals, Inc.  NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing…

Continue Reading

Monday May 12, 2025 - 9:10 am

InvestorNewsBreaks – Oragenics Inc. (NYSE American: OGEN) to Host May 20 Webinar on Concussion Drug Program ONP-002

Oragenics (NYSE American: OGEN) will host a management update webinar on Tuesday, May 20, 2025, at 4:00 p.m. ET to discuss the unmet medical need in concussion treatment and highlight its lead candidate, ONP-002. The intranasal therapy is currently in a Phase IIa trial for mild traumatic brain injury and has shown promising preclinical results in reducing brain inflammation and swelling. Presenters will include CEO…

Continue Reading

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(862) 930-1404

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).